T0	Outcomes 1008 1043	median number of aflibercept cycles
T1	Outcomes 1137 1168	were neutropenia (37%), fatigue
T2	Outcomes 1175 1191	and hypertension
T3	Outcomes 1337 1346	patients.
T4	Outcomes 1347 1426	Plasma levels of free over vascular endothelial growth factor-bound aflibercept